logo

For the Inventor, By the Inventor

Tokyo, Japan

Hideo Nakao

USPTO Granted Patents = 13 

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Hiromachi, JA (1977)
  • Tokyo, JA (1977 - 1978)
  • Hiromachi, JP (1978 - 1984)
  • Tokyo, JP (1987)

Company Filing History:

goldMedal13 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1977-1987

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4716158 - 7-(2-amin (1987-12-29),
2. 4486425 - 7-[2-(2-A (1984-12-04),
3. 4483855 - Cephalosporin derivative and antibiotic compositions (1984-11-20),
4. 4482710 - Process for preparing 3-alkoxymethylcephalosporin derivatives (1984-11-13),
5. 4247548 - 7.alpha.-Methoxycephalosporin derivatives and their pharmaceutical (1981-01-27),
6. 4126745 - 7-Methoxycephalosporin derivatives (1978-11-21),
7. 4071681 - Process for preparing beta-lactam antibiotic substances (1978-01-31),
8. 4051320 - Process for preparing alkoxylated derivatives of cephalosporin compounds (1977-09-27),
9. 4051129 - Process for preparing 7-methoxycephalosporin compounds (1977-09-27),
10. 4048155 - Process for preparing 7 .alpha.-alkoxycephalosporin derivatives (1977-09-13),
11. 4016155 - Process for preparing cephalosporin derivatives (1977-04-05),
12. 4007177 - Cephalosporin derivatives (1977-02-08),
13. 4003901 - Nitrosourea derivative (1977-01-18),

Title: Hideo Nakao: A Pioneer in Pharmaceutical Innovations

Introduction

Hideo Nakao, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 13 patents, he is recognized for his innovative approaches and advancements in drug development. His work primarily focuses on the synthesis of unique chemical compounds that exhibit potential therapeutic properties.

Latest Patents

Among Hideo Nakao's most notable recent patents are the compounds described as 7-(2-amin - Compounds of formula (I): where R¹ represents a lower alkyl group selected from methyl and ethyl groups. Additionally, he holds a patent for 7-[2-(2-A - Compounds of formula (I): which mirrors the innovation seen in his previous work by also featuring R¹ as a lower alkyl group. These patents reflect his dedication to exploring new chemical entities that may lead to effective treatments.

Career Highlights

Nakao is associated with Sankyo Company, Limited, a well-respected entity in the pharmaceutical industry. His career is highlighted by his innovative contributions that not only advance scientific knowledge but also have the potential to enhance patient care. His work plays a crucial role in the development of new medications that can improve health outcomes globally.

Collaborations

Throughout his career, Hideo Nakao has collaborated with esteemed colleagues such as Hiroaki Yanagisawa and Shinichi Sugawara. These partnerships have sparked creative synergies that have likely contributed to the success of his research and the formulation of groundbreaking pharmaceuticals.

Conclusion

In summary, Hideo Nakao stands out as a dedicated inventor whose patents reflect a commitment to advancing pharmaceutical innovation. His work at Sankyo Company, Limited, alongside esteemed colleagues, continues to push the boundaries of drug development, offering hope for future medical advancements. With his notable contributions, Nakao is poised to remain an influential figure in the world of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…